Healthcare Purchasing News

The Maturation of Clinically Integrated Supply Chain Maturity Models

share us

  • May 31, 2021

Over the past few years, multiple organizations have offered definitions of a clinically integrated supply chain that generally fall into two areas of emphasis:

  • Using clinical evidence to reduce unwarranted variation in how care is delivered, resulting in lower costs and better-quality care
  • Tracking inventory utilization to minimize medical errors and adverse events and generate real world evidence on what works best on which patient population

GHX’s Karen Conway explains why it’s not about choosing one model over the other, but rather understanding the full breadth of clinical-supply chain integration.

About the Author

Karen ConwayKaren Conway, Vice President, Healthcare Value, GHX

Karen works to advance the role of the supply chain as a critical enabler of a value-based healthcare system. In her role at GHX, she applies her extensive knowledge of supply chain operations and systems thinking to align processes, data and incentives across the healthcare ecosystem. Karen was named a 2019 “Pro to Know” by Supply and Demand Chain Executive

Read Article Now